Copy For Citation
Korkmaz S., Dal M. S., Berber I., Sahin D. G., Dogu M. H., Ayyildiz O., ...More
GERIATRICS & GERONTOLOGY INTERNATIONAL, vol.15, no.6, pp.729-735, 2015 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
15
Issue:
6
-
Publication Date:
2015
-
Doi Number:
10.1111/ggi.12341
-
Journal Name:
GERIATRICS & GERONTOLOGY INTERNATIONAL
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
-
Page Numbers:
pp.729-735
-
Keywords:
chronic myeloid leukemia, dasatinib, elderly patients, imatinib, nilotinib, CHRONIC-PHASE, MYELOPROLIFERATIVE DISORDERS, 1ST-LINE TREATMENT, IMATINIB TREATMENT, CML, INTERFERON, RECOMMENDATIONS, CYTARABINE, MANAGEMENT, NILOTINIB
-
Van Yüzüncü Yıl University Affiliated:
Yes
Abstract
AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase inhibitors (TKI) therapy.